Get started
Author

Lufeng Zheng

Observed names: LUFENG ZHENG, Zheng Lufeng, Zheng, Lufeng
ORCID: 0000-0002-2183-4974
Observed ORCID: 0000-0002-2183-4974
OpenAlex ID: A5083840214
RNA-binding proteins in tumor progression
2020 · Hai Qin, Haiwei Ni, et al. · Journal of Hematology & Oncology · 387
PDF
MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis
2021 · Haiwei Ni, Hai Qin, et al. · Stem Cell Research & Therapy · 183
PDF
Emerging agents that target signaling pathways in cancer stem cells
2020 · Yue Yang, Xiaoman Li, et al. · Journal of Hematology & Oncology · 182
PDF
MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42
2016 · Jinjiang Chou, Bingyu Wang, et al. · Biochemical and Biophysical Research Communications · 182
The Role of Iron in Cancer Progression
2021 · Qianqian Guo, Liwen Li, et al. · Frontiers in Oncology · 161
PDF
MiR-873/PD-L1 axis regulates the stemness of breast cancer cells
2019 · Lanlan Gao, Qianqian Guo, et al. · EBioMedicine · 158
PDF
The 3′UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1
2015 · Lufeng Zheng, Xiaoman Li, et al. · Breast Cancer Research and Treatment · 133
STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling
2018 · Lufeng Zheng, Chenxi Xiang, et al. · Journal of Hematology & Oncology · 130
PDF
Hsa_circ_0136666 stimulates gastric cancer progression and tumor immune escape by regulating the miR-375/PRKDC Axis and PD-L1 phosphorylation
2023 · Zhenyan Miao, Jifei Li, et al. · Molecular Cancer · 115
PDF
Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression
2021 · Yingying Xing, Guojing Ruan, et al. · Frontiers in Immunology · 99
PDF
MicroRNA-9 and breast cancer
2019 · Xiaoman Li, Zhu Zeng, et al. · Biomedicine & Pharmacotherapy · 94
PDF
Limonin ameliorates ulcerative colitis by regulating STAT3/miR-214 signaling pathway
2019 · Shijia Liu, Shufang Zhang, et al. · International Immunopharmacology · 86
STARD13-correlated ceRNA network inhibits EMT and metastasis of breast cancer
2016 · Xiaoman Li, Lufeng Zheng, et al. · Oncotarget · 78
PDF
Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells
2019 · Lufeng Zheng, Qianqian Guo, et al. · Journal of Hematology & Oncology · 76
PDF
Tanshinone IIA inhibits gastric cancer cell stemness through inducing ferroptosis
2021 · Haiwei Ni, Guojing Ruan, et al. · Environmental Toxicology · 72
Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting
2023 · Qianqian Guo, Yi Zhou, et al. · Genes & Diseases · 66
miR‐125a‐3p inhibits ERα transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor–positive breast cancer
2017 · Lufeng Zheng, Xia Meng, et al. · The FASEB Journal · 66
Competing endogenous RNA networks of CYP4Z1 and pseudogene CYP4Z2P confer tamoxifen resistance in breast cancer
2016 · Lufeng Zheng, Xiaoman Li, et al. · Molecular and Cellular Endocrinology · 66
Discovery of a Dual Tubulin and Poly(ADP-Ribose) Polymerase-1 Inhibitor by Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, and Biological Evaluation
2021 · Lufeng Zheng, Ren Ren, et al. · Journal of Medicinal Chemistry · 60
Correction to: Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells
2019 · Lufeng Zheng, Qianqian Guo, et al. · Journal of Hematology & Oncology · 52
PDF
The Functional Roles of ISG15/ISGylation in Cancer
2023 · Yin Yuan, Hai Qin, et al. · Molecules · 44
PDF
RNA Binding Protein RNPC1 Inhibits Breast Cancer Cell Metastasis via Activating STARD13-Correlated ceRNA Network
2018 · Lufeng Zheng, Zhiting Zhang, et al. · Molecular Pharmaceutics · 43
Anti-angiogenic effect of tanshinone IIA involves inhibition of the VEGF/VEGFR2 pathway in vascular endothelial cells
2014 · YINGYING XING, JIAJIE TU, et al. · Oncology Reports · 43
PDF
The CCR2 3′UTR functions as a competing endogenous RNA to inhibit breast cancer metastasis
2017 · Jinhang Hu, Xiaoman Li, et al. · Journal of Cell Science · 40
RETRACTED: Lnc RNA FENDRR attenuates adriamycin resistance via suppressing MDR 1 expression through sponging HuR and miR‐184 in chronic myelogenous leukaemia cells
2019 · Feng Zhang, Haiwei Ni, et al. · FEBS Letters · 38
PDF
Works count: 86
Citation count: 3,443
H-index: 33
I10-index: 55
Year
Topic
Type